Bayforest Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Bayforest Capital's RGEN Position: Q2 2026 in Review
Bayforest Capital reduced its Repligen (RGEN) stake by 49% in Q2 2026, selling an estimated $2.33K and leaving 20 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #879.
Bayforest Capital first reported a position in RGEN in Q4 2024 and has held it in 4 quarters since. The position peaked at $70.2K in Q4 2024. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Bayforest Capital held 20 shares of Repligen worth $2.73K as of Q2 2026.
- Bayforest Capital sold 19 Repligen shares in Q2 2026, an estimated $2.33K.
- Repligen made up ﹤0.01% of Bayforest Capital's portfolio in Q2 2026, its #879 holding.
- Bayforest Capital first reported a position in Repligen in Q4 2024 and has held it in 4 quarters since.
- Bayforest Capital's Repligen position peaked at $70.2K in Q4 2024.
- 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.